Last update :
27/11/2024
References   References 3893  
Type : Journal
Web link : http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386

Research teams : Montreal - Faculté de pharmacie, Université de Montréal
Authors : Friciu M, Zaraa S, Leclair G.
Title : Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions
Reference : Can J Hosp Pharm ; 69, 4: 327-329. 2016

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionAmlodipine besylate Antihypertensive
Stability in solutions Glass tablets 30 mg
Norvasc®
Oral Mix® >> 30 ml
23-27°C Protect from light
60 Day
Stability in solutions Glass powder 30 mg
® = Medisca Pharmaceutique Inc
Oral Mix® >> 30 ml
23-27°C Protect from light
60 Day
Stability in solutions Glass tablets 30 mg
Norvasc®
Oral Mix® >> 30 ml
3-7°C Protect from light
90 Day
Stability in solutions Glass powder 30 mg
® = Medisca Pharmaceutique Inc
Oral Mix® >> 30 ml
3-7°C Protect from light
90 Day
Stability in solutions syringe tablets 1 mg
Norvasc®
Oral Mix® >> 1 ml
23-27°C Protect from light
45 Day
Stability in solutions syringe powder 1 mg
® = Medisca Pharmaceutique Inc
Oral Mix® >> 1 ml
23-27°C Protect from light
45 Day
Stability in solutions syringe tablets 1 mg
Norvasc®
Oral Mix® >> 1 ml
3-7°C Protect from light
90 Day
Stability in solutions syringe powder 1 mg
® = Medisca Pharmaceutique Inc
Oral Mix® >> 1 ml
3-7°C Protect from light
90 Day

  Mentions Légales